Antitumor effect fortifier, antitumor agent and method of therapy for cancer

Details for Australian Patent Application No. 2005251588 (hide)

Owner Taiho Pharmaceutical Co., Ltd.

Inventors Takechi, Teiji; Uchida, Junji; Nukatsuka, Mamoru; Koizumi, Katsuhisa

Agent Griffith Hack

Pub. Number AU-B-2005251588

PCT Pub. Number WO2005/120480

Priority 2004-171520 09.06.04 JP

Filing date 2 June 2005

Wipo publication date 22 December 2005

Acceptance publication date 8 January 2009

International Classifications

A61K 31/132 (2006.01) - having two or more amino groups, e.g. spermidine, putrescine

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/120480 Priority application(s): WO2005/120480

8 January 2009 Application Accepted

  Published as AU-B-2005251588

7 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005251589-Drug having regulatory cell ligand contained in liposome

2005251579-Method of growing plant and apparatus therefor